MY112586A - Isoxazoline compounds as 5-lipoxygenase inhibitors - Google Patents

Isoxazoline compounds as 5-lipoxygenase inhibitors

Info

Publication number
MY112586A
MY112586A MYPI95000574A MYPI19950574A MY112586A MY 112586 A MY112586 A MY 112586A MY PI95000574 A MYPI95000574 A MY PI95000574A MY PI19950574 A MYPI19950574 A MY PI19950574A MY 112586 A MY112586 A MY 112586A
Authority
MY
Malaysia
Prior art keywords
isoxazoline compounds
lipoxygenase inhibitors
relates
dermatitis
lipoxygenase
Prior art date
Application number
MYPI95000574A
Other languages
English (en)
Inventor
F Kleinman Edward
L Cohan Victoria
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of MY112586A publication Critical patent/MY112586A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Cardiology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Nutrition Science (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
MYPI95000574A 1994-03-09 1995-03-07 Isoxazoline compounds as 5-lipoxygenase inhibitors MY112586A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US20876894A 1994-03-09 1994-03-09

Publications (1)

Publication Number Publication Date
MY112586A true MY112586A (en) 2001-07-31

Family

ID=22775981

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI95000574A MY112586A (en) 1994-03-09 1995-03-07 Isoxazoline compounds as 5-lipoxygenase inhibitors

Country Status (11)

Country Link
US (1) US5696141A (fr)
EP (1) EP0749307A1 (fr)
JP (1) JPH09505081A (fr)
AU (1) AU1326795A (fr)
CA (1) CA2184914C (fr)
FI (1) FI963509L (fr)
IL (1) IL112849A (fr)
MX (1) MX9603943A (fr)
MY (1) MY112586A (fr)
WO (1) WO1995024192A1 (fr)
ZA (1) ZA951911B (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104042617A (zh) 2009-04-29 2014-09-17 阿马里纳药物爱尔兰有限公司 含有epa和心血管剂的药物组合物以及使用其的方法

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS62103070A (ja) * 1985-10-29 1987-05-13 Mitsui Toatsu Chem Inc イソオキサゾリン誘導体および植物生長調節剤
FI875724L (fi) * 1986-04-29 1987-12-28 Pfizer Av kalcium oberoende camp fosfodiesteras-inhibitordepressant.
IE59813B1 (en) * 1986-05-09 1994-04-06 Warner Lambert Co Styryl pyrazoles, isoxazoles and analogs thereof having activity as 5-lipoxy-genase inhibitors and pharmaceutical compositions containing them
US4731382A (en) * 1986-12-29 1988-03-15 Bristol-Myers Company Lipoxygenase inhibitory phenylalkanohydroxamic acids
FR2639636B1 (fr) * 1988-11-30 1994-03-04 Novapharme Nouveaux composes heterocycliques a activite anticonvulsivante, procede de preparation et compositions therapeutiques les contenant
IL92915A0 (en) * 1989-01-05 1990-09-17 Ciba Geigy Ag Certain pyrrolylphenyl-substituted hydroxamic acid derivatives
CA2017383A1 (fr) * 1989-06-08 1990-12-08 Raymond R. Martodam Utilisation de vanilloides pour le traitement des affections ou des troubles respiratoires
WO1991007177A1 (fr) * 1989-11-13 1991-05-30 Pfizer Inc. Derives de pyrimidone et analogues pour le traitement de l'asthme et de certaines maladies de la peau
DE3939010A1 (de) * 1989-11-25 1991-05-29 Hoechst Ag Isoxazoline, verfahren zu ihrer herstellung und ihre verwendung als pflanzenschuetzende mittel
JP2787602B2 (ja) * 1990-01-24 1998-08-20 大鵬薬品工業株式会社 イソキサゾリン誘導体
US5234937A (en) * 1990-03-27 1993-08-10 Warner-Lambert Company 3,5-di-tertiary-butyl-4-hydroxphenyl oxazolyl methanones and related compounds as antiinflammatory agents
GB9007762D0 (en) * 1990-04-05 1990-06-06 Beecham Group Plc Novel compounds
JPH06501708A (ja) * 1990-11-06 1994-02-24 スミスクライン・ビーチャム・コーポレイション イミダゾリジノン化合物
PT100441A (pt) * 1991-05-02 1993-09-30 Smithkline Beecham Corp Pirrolidinonas, seu processo de preparacao, composicoes farmaceuticas que as contem e uso
US5140047A (en) * 1991-05-03 1992-08-18 Smithkline Beecham Corporation Lipoxygenase inhibitors
GB9215921D0 (en) * 1992-07-27 1992-09-09 Wellcome Found Anti-inflammatory compounds
US5288397A (en) * 1992-09-18 1994-02-22 Mobil Oil Corporation Baffled FCC regeneration process and apparatus
WO1994018158A1 (fr) * 1993-02-15 1994-08-18 Pfizer Inc. Spiroalkylhydroxyurees utilisees comme inhibiteurs de lipoxygenase

Also Published As

Publication number Publication date
CA2184914A1 (fr) 1995-09-14
IL112849A0 (en) 1995-06-29
WO1995024192A1 (fr) 1995-09-14
US5696141A (en) 1997-12-09
FI963509A0 (fi) 1996-09-06
EP0749307A1 (fr) 1996-12-27
AU1326795A (en) 1995-09-25
MX9603943A (es) 1997-04-30
JPH09505081A (ja) 1997-05-20
ZA951911B (en) 1996-09-09
CA2184914C (fr) 2000-09-19
FI963509A7 (fi) 1996-09-06
FI963509L (fi) 1996-09-06
IL112849A (en) 1999-04-11

Similar Documents

Publication Publication Date Title
GR3032506T3 (en) 3-aryl-2-isoxazolines as antiinflammatory agents
BR9408174A (pt) Compostos isoxazolina como agentes antiinflamatórios
GR3035821T3 (en) Substituted indoles as phosphodiesterase type iv inhibitors
WO1999061013A3 (fr) COMPOSES AYANT DES PROPRIETES AFFECTANT LES IgE
MXPA02011311A (es) Composicion novedosa.
WO2007036745A3 (fr) Composition comprenant un anticorps anti-interleukine 13
SG155909A1 (en) Pyridazin-3(2h)-one derivatives and their use as pde4 inhibitors
NO963746L (no) Isoksalin-forbindelser som inhibitorer for frigivning av TNF
SG155943A1 (en) Pyridazin-3(2h)-one derivatives and their use as pde4 inhibitors
MXPA05012086A (es) Inhibidores de benzamida del receptor p2x7.
EP1703893A4 (fr) Nouveaux anticorps anti-il 13 et utilisations associees
CA2150812A1 (fr) Diethers de catechol utilises comme inhibiteurs selectifs de la phosphodiesterase de type iv
WO1999065449A8 (fr) INHIBITEURS DU FACTEUR DE TRANSCRIPTION NF-λB
WO2003041643A3 (fr) Composes de zearalanol inhibant hsp90 et leurs procedes de production et d'utilisation
MXPA04004300A (es) Analogos de lipoxina a4.
DK0980374T3 (da) Phosphodiesterase 4-inhiberende diazepinoindoloner.
CA2186513A1 (fr) Derives benzisothiazoles en tant qu'inhibiteurs de la biosynthese de la 5-lipoxygenase
MY112586A (en) Isoxazoline compounds as 5-lipoxygenase inhibitors
SE9900834D0 (sv) Novel combination
WO2002083700A3 (fr) Disaccharides hypersulfates et leur utilisation en traitement contre les inflammations
MX9603821A (es) Carbamatos biciclicos.